• Our Company

QuintilesIMS Delivers Integrated Information and Technology Solutions to Drive Healthcare Forward

Around the world healthcare stakeholders are working to improve real-world patient outcomes through treatment innovations, care provision and access to healthcare. For the information, technology and service solutions they need to drive new insights and approaches, they count on QuintilesIMS. With a global team of 50,000, we harness insights, commercial and scientific depth, and executional expertise to empower clients to achieve some of their most important goals: Improving clinical, scientific and commercial results. Realizing the full potential of innovations. And, ultimately, driving healthcare forward.

For more information please visit www.quintilesims.com.

Driving Healthcare Performance in Indonesia

In 2015, QuintilesIMS Indonesia made significant investment to further improve the quality of sales audits and to better align with our clients' needs. The initiatives put in place will significantly improve our coverage and closely align with current market dynamics. These sales audits focus on the coverage of different channels such as drugstore, hospital, and pharmacy channels.

Based on QuintilesIMS Market Prognosis (Sep. 2016), the Indonesian pharmaceutical market is forecast to grow at a compound annual growth rate (CAGR) of 5.7% (±2.5%) between 2015 and 2020, reaching Rp 74,168 billion by 2020.

Indonesia continues to expand and improve its basic public healthcare services and the private hospital sector is also expanding. From 2014 onwards, the implementation of a National Health Insurance (NHI) system, will help increase access to healthcare and drive volume growth, mainly for unbranded generics. The use of generics will be encouraged in the public hospital sector, especially after the implementation of the NHI scheme.

In today's highly competitive and complex environment, contact your QuintilesIMS Indonesia representative to gain greater clarity and stay one step ahead of the competition with the valuable insights gained from QuintilesIMS offerings.